Enlarge Photo

An undated photo provided by Dr. Christopher Cannon shows Dr. Christopher Cannon of Brigham and Women's Hospital in Boston. Cannon is the leader of a study on an experimental Merck drug that safely boosted good cholesterol to record highs while dropping bad cholesterol to unprecedented lows in a study that stunned researchers and renewed hopes for an entirely new way of lowering heart risks. The study results were presented Wednesday, Nov. 17, 2010 at an American Heart Association conference in Chicago. (AP Photo/Dr. Christopher Cannon) NO SALES

Happening Now